Related Experiment Video
Updated: Jun 5, 2026

07:47
Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
EMT is the dominant program in human colon cancer
Andre Loboda1, Michael V Nebozhyn, James W Watters
1Merck, Sharp and Dohme, West Point, PA 19486, USA.
BMC Medical Genomics
|January 22, 2011
Summary
Colon cancer subtypes were identified using gene expression patterns. The primary molecular subtype (PC1) strongly correlates with epithelial-mesenchymal transition (EMT), revealing underlying biology.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Colon cancer prognosis is traditionally determined post-surgery using clinicopathologic features.
- Existing methods offer limited predictive power before invasive procedures.
Purpose of the Study:
- To identify intrinsic molecular subtypes of colon cancer using gene expression data.
- To determine if molecular subtypes can predict disease progression and recurrence.
Main Methods:
- Unsupervised analysis of microarray data from 326 colon cancer samples.
- Identification of the first principal component (PC1) representing the most variable gene expression patterns.
- Correlation analysis between PC1 and the epithelial-mesenchymal transition (EMT) signature.
- MicroRNA screening to identify regulators of PC1.
Main Results:
- PC1 identified two intrinsic molecular subtypes of colon cancer.
- PC1 strongly correlated with the EMT signature (Pearson R = 0.92, P < 10(-135)).
- MicroRNA-200 (MiR200) was identified as the most anti-correlated microRNA with PC1, known to regulate EMT.
Conclusions:
- Colon cancer biology can be clarified through transcriptome analysis, revealing intrinsic molecular subtypes.
- The dominant gene expression pattern (PC1) is linked to EMT, providing a molecular basis for classification.
- This approach offers a new perspective on the heterogeneity of colon cancer.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

